Rocket Pharmaceuticals, Inc.
RCKTBiotechnology
$2.44−3.94%As of Oct 30vs prior close
- Market cap
- $267.9M
- P/E (TTM)
- –
- From 52W high
- −53.96%
- EPS (YE25)
- -$2.01
- Revenue (YE25)
- $0
- Dividend yield
- 0.00%
Nomior Score
23
Fragile PremiumBottom 9% of the scored universe
Growth63
Quality30
Value24
Momentum25
Resilience32
Growth
$0revenue, YE25
YE16 $0YE25 $0
Connections
Who owns it
2funds, 1 tracked portfolio